J. Vignoud

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

D. Machover, Eduardo Díaz‐Rubio, Aimery de Gramont et al. · Annals of Oncology · 1996 · 433 citations · Full text

Oncology, Medicine, Colorectal Cancer +5

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

Aimery de Gramont, J. Vignoud, Christophe Tournigand et al. · European Journal of Cancer · 1997 · 385 citations

Oncology, Medicine, Colorectal Cancer +4

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 125 citations

Breast Oncology, Oncology, Early Breast Cancer +6

Final Results of a Randomized Trial Comparing Chemotherapy Plus Radiotherapy With Chemotherapy Plus Surgery Plus Radiotherapy in Locally Advanced Resectable Hypopharyngeal Carcinomas

Céline Beauvillain, M.-A. Mahé, S. Bourdin et al. · The Laryngoscope · 1997 · 99 citations

933 Oxaliplatin (L-OHP®): Global safety in 682 patients (PTS)

S. Brienza, J. Vignoud, M. Itzhaki et al. · European Journal of Cancer · 1995 · 36 citations

Drug Safety, Therapeutic Drug Monitoring, Global Safety +6